Wisconsin Immunization Program Update
Friday, June 16, 2017
Trumenba Scheduling Update
Trumenba is one of two vaccines which help protect against meningococcal disease caused by Neisseria meningitidis serogroup B. The CDC recently revised the scheduling for Trumenba to include three dose and two dose schedules depending on an individual's risk. Please note that the schedule for Bexsero remains unchanged. You can find the Trumenba schedule changes in the MMWR article published on May 19, 2017.
The Wisconsin Immunization Program is working diligently to implement the new Trumenba schedule to the Wisconsin Immunization Registry (WIR). An update will be sent to providers via a WIR announcement upon completion of the change. In the meantime, follow the schedule according to your clinic's policy. Upon vaccination series initiation, the WIR will continue to forecast the three dose series until scheduling changes are implemented. If you have any questions, please contact the WIR help desk at firstname.lastname@example.org or call (608) 266-9691.
Update on MenHibrix Vaccine
GSK is discontinuing the manufacture and sale of MenHibrix [Meningococcal Groups C and Y and Haemophilus b Tetanus Toxoid Conjugate Vaccine] in the U.S. Effective immediately, GSK will stop producing new lots of MenHibrix. GSK will continue to manufacture MENVEO® and HIBERIX® to cover the medical need.
For providers that order from the CDC contract, including Wisconsin VFC providers, the current CDC inventory of MenHibrix has an expiration of September 17, 2017. The vaccine has been blocked from ordering through the WIR for Wisconsin VFC providers.
For specific questions on MenHibrix please reach out to GSK contact Customer Service at 1-800-877-1158 or contact your GSK Public Account Manager.
Minnesota Measles Outbreak-Update
The Minnesota Department of Health announced on June 15, 2017 that there are 77 total measles cases related to the outbreak that began in April 2017. Of the 76 measles cases, 71 were unvaccinated against measles disease. The majority of cases have been in Hennepin County which includes the city of Minneapolis and some surrounding suburbs.
Health care providers should continue to ensure their patients are protected against measles disease and vaccinate according to the ACIP recommendations. If there is a suspected or confirmed case, providers should take immediate steps outlined on the Wisconsin Immunization Measles web page, including immediate reporting of suspect cases to the local health department.
HPV Immunization Media Campaign
The Immunization Program has launched a media campaign to encourage parents to vaccinate against cancer with the HPV vaccine. The campaign will run from May 29, 2017-July 30, 2017. The campaign includes:
- A 4 week radio schedule in LaCrosse, Eau Claire, Platteville and Wausau areas
- Across the state, there will be ads on YouTube and Centro DPS channels. These ads will include a video of a cervical cancer survivor.
- Additional online ads will be shown next to newspaper and magazine websites.
The ad messaging coincides with the back-to-school time frame when pre-teens are likely to visit there health care provider. A health care provider is still a parent's most trusted resource for health information. That is why it is important to give a strong recommendation for the HPV vaccine as with any other vaccine. You can try saying "Today your 11 year old needs three vaccines: Tdap, HPV, and MCV4." You can find health care provider resources, including tips and time savers, on the CDC's website.